|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | |||
| Marketable securities at fair value | |||
| Prepaid expenses and other current assets | |||
| Total current assets | |||
| Non-current assets: | |||
| Property, plant and equipment, net | |||
| Right-of-use asset and other non-current assets | |||
| Total non-current assets | |||
| Total assets | |||
| Liabilities and stockholders’ equity (deficit) | |||
| Current liabilities: | |||
| Accounts payable | |||
| Accrued expenses | |||
| Other current liabilities and lease liabilities | |||
| Total current liabilities | |||
| Lease liabilities - non-current | |||
| Total liabilities | |||
| Redeemable convertible preferred stock: | |||
| Redeemable convertible preferred stock | |||
| Series A preferred stock | |||
| Series B preferred stock | |||
| Series C preferred stock | |||
| Subscription receivable | |||
| Stockholders’ equity (deficit) | |||
| Preferred stock, $0.00001 par value, 25,000,000 and 0 shares authorized as of June 30, 2026 and December 31, 2025, respectively and 0 shares issued or outstanding as of June 30, 2026 and December 31, 2025, respectively | |||
| Common stock, $0.00001 par value, 200,000,000 and 267,466,797 shares authorized as of June 30, 2026 and December 31, 2025, respectively and 41,780,136 and 749,760 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||
| Additional paid-in capital | |||
| Subscription receivable | |||
| Accumulated other comprehensive (loss) income | |||
| Accumulated deficit | |||
| Total stockholders’ equity (deficit) | |||
| Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit) | |||
| Common stock, authorized (in shares) |
Loading...
